384
Views
26
CrossRef citations to date
0
Altmetric
Research Article

A randomised, double-blind comparison of 20 units of onabotulinumtoxinA with 30 units of incobotulinumtoxinA for glabellar lines

, , , , , , , , & show all
Pages 296-303 | Received 02 May 2012, Accepted 05 Oct 2012, Published online: 15 Nov 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

David C Rupp, David Canty, Catherine Rhéaume, Birgitte Sondergaard, Celina Niño, Ron S Broide & Amy D Brideau-Andersen. (2023) A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA. Clinical, Cosmetic and Investigational Dermatology 16, pages 581-591.
Read now
Yana Yutskovskaya, Elena Gubanova, Irina Khrustaleva, Vasiliy Atamanov, Anastasiya Saybel, Elena Parsagashvili, Irina Dmitrieva, Elena Sanchez, Natalia Lapatina, Tatiana Korolkova, Alena Saromytskaya, Elena Goltsova & Elmira Satardinova. (2015) IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations. Clinical, Cosmetic and Investigational Dermatology 8, pages 297-306.
Read now
Mitchell F Brin, Charmaine James & John Maltman. (2014) Botulinum toxin type A products are not interchangeable: a review of the evidence. Biologics: Targets and Therapy 8, pages 227-241.
Read now

Articles from other publishers (23)

Xue Li, Changlin Sui, Xiujuan Xia & Xianjin Chen. (2022) Efficacy and Safety of Botulinum Toxin Type A for Treatment of Glabellar Lines: A Network Meta-Analysis of Randomized Controlled Trials. Aesthetic Plastic Surgery 47:1, pages 365-377.
Crossref
Sung Ok Hong. (2023) Cosmetic Treatment Using Botulinum Toxin in the Oral and Maxillofacial Area: A Narrative Review of Esthetic Techniques. Toxins 15:2, pages 82.
Crossref
Annica C. Eells, Lisa D. Grunebaum & Brittany E. Howard. (2022) Incobotulinum toxin A: A shelf‐stable, low‐molecular‐weight formulation. Dermatological Reviews 3:4, pages 211-217.
Crossref
David Zargaran, Florence Zoller, Alexander Zargaran, Eqram Rahman, Alexander Woollard, Tim Weyrich & Afshin Mosahebi. (2022) Complications of Cosmetic Botulinum Toxin A Injections to the Upper Face: A Systematic Review and Meta-Analysis. Aesthetic Surgery Journal 42:5, pages NP327-NP336.
Crossref
Wolfgang G. Philipp-Dormston, Dario Bertossi, Khosrow Houschyar & Eqram Rahman. (2022) Botulinum Toxins for Esthetic Facial Injections: A Scientific Review to Support Evidence-Based Best Practice. Facial Plastic Surgery 38:02, pages 152-155.
Crossref
Ya.A. Yutskovskaya, A.V. Saybel, L.R. Chakhoyan, A.A. Supilnikov, T.A. Ovcharenko, A.Yu. Terentyev & E.A. Mishurinskaya. (2022) Variable anatomy of facial muscles in the light of botulinum toxin injections. Plasticheskaya khirurgiya i esteticheskaya meditsina:4, pages 102.
Crossref
Cristina Pires Camargo, Jun Xia, Caroline S Costa, Rolf Gemperli, Maria DC Tatini, Max K Bulsara & Rachel Riera. (2021) Botulinum toxin type A for facial wrinkles. Cochrane Database of Systematic Reviews 2022:1.
Crossref
David Rupp, Greg Nicholson, David Canty, Joanne Wang, Catherine Rhéaume, Linh Le, Lance E. Steward, Mark Washburn, Birgitte P. Jacky, Ron S. Broide, Wolfgang G. Philipp-Dormston, Mitchell F. Brin & Amy Brideau-Andersen. (2020) OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays. Toxins 12:6, pages 393.
Crossref
Andrew J. ThomasMichael O. LarsonSamuel BradenRichard B. CannonP. Daniel Ward. (2018) Effect of 3 Commercially Available Botulinum Toxin Neuromodulators on Facial Synkinesis. JAMA Facial Plastic Surgery 20:2, pages 141-147.
Crossref
William P. ColemanGerhard SattlerPetra WeissenbergerMichael A. Hast & Angelika Hanschmann. (2017) Safety of IncobotulinumtoxinA in the Treatment of Facial Lines: Results From a Pooled Analysis of Randomized, Prospective, Controlled Clinical Studies. Dermatologic Surgery 43:3, pages S293-S303.
Crossref
Ulrich Kühne & Matthias Imhof. 2017. Botulinum Toxins. Botulinum Toxins 79 95 .
Welf PragerDiana Nogueira TeixeiraPhillip S. Leventhal. (2017) IncobotulinumtoxinA for Aesthetic Indications: A Systematic Review of Prospective Comparative Trials. Dermatologic Surgery 43:7, pages 959-966.
Crossref
Alisa A Sharova. (2016) Comparison of different consensuses of BTXA in different countries. Journal of Cosmetic Dermatology 15:4, pages 540-548.
Crossref
Marie E. Noland, Donald H. Lalonde, G. Jackie Yee & Rod J. Rohrich. (2016) Current Uses of Botulinum Neurotoxins in Plastic Surgery. Plastic & Reconstructive Surgery 138:3, pages 519e-530e.
Crossref
Anthony J. Wilson, Brian Chang, Anthony J. Taglienti, Bianca C. Chin, Catherine S. Chang, Nancy Folsom & Ivona Percec. (2016) A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction. Plastic & Reconstructive Surgery 137:5, pages 1424-1433.
Crossref
James P. Bonaparte, David Ellis, Jason G. Quinn, Jessica Rabski & Brian Hutton. (2016) A Comparative Assessment of Three Formulations of Botulinum Toxin Type A for Facial Rhytides: A Systematic Review with Meta-Analyses. Plastic & Reconstructive Surgery 137:4, pages 1125-1140.
Crossref
Hyun-Mi Oh, Joo Park, Dae Song & Myung Chung. (2015) Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins. Toxins 8:1, pages 4.
Crossref
Anna Rita Bentivoglio, Alessandra Del Grande, Martina Petracca, Tamara Ialongo & Lucia Ricciardi. (2015) Clinical differences between botulinum neurotoxin type A and B. Toxicon 107, pages 77-84.
Crossref
Michael A. C. Kane, Michael H. Gold, William P. Coleman, Derek H. Jones, Emil A. Tanghetti, Tina S. Alster, Tom E. Rohrer, Cheryl M. Burgess, Ava T. Shamban & Eleanor Finn. (2015) A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines. Dermatologic Surgery 41:11, pages 1310-1319.
Crossref
Jürgen Frevert. (2015) Response to Commentary by W. Jost on: Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products. Drugs in R&D 15:2, pages 217-218.
Crossref
Ruth Hill Yeilding & John P. Fezza. (2015) A Prospective, Split-Face, Randomized, Double-Blind Study Comparing OnabotulinumtoxinA to IncobotulinumtoxinA for Upper Face Wrinkles. Plastic and Reconstructive Surgery 135:5, pages 1328-1335.
Crossref
Wolfgang H. Jost. (2015) ‘Similar To’ Is Not ‘Identical With’, and ‘Identical With’ Is Not ‘The Same As’. Drugs in R&D 15:1, pages 11-12.
Crossref
Berthold Rzany. 2014. Evidence-Based Dermatology. Evidence-Based Dermatology 516 522 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.